Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow

被引:0
|
作者
Ulbrich, H
Eriksson, EE
Xie, X
Soehnlein, O
Lindbom, L
Laufer, S
Dannhardt, G
机构
[1] Univ Mainz, Inst Pharm, Dept Pharmaceut & Med Chem, D-6500 Mainz, Germany
[2] Dept Physiol & Pharmacol, Stockholm, Sweden
[3] Univ Tubingen, Inst Pharm, Dept Pharmaceut & Med Chem, Tubingen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:137 / 137
页数:1
相关论文
共 34 条
  • [31] Licofelone -: an inhibitor of 5-LOX, COX-1 and COX-2 has superior GI tolerability in OA patients compared with naproxen, regardless of low-dose aspirin co-medication, previous ulcer history or H-pylori status.
    Bias, P
    Buchner, A
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S72 - S72
  • [32] A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow
    Alon, R
    Aker, M
    Feigelson, S
    Sokolovsky-Eisenberg, M
    Staunton, DE
    Cinamon, G
    Grabovsky, V
    Shamri, R
    Etzioni, A
    BLOOD, 2003, 101 (11) : 4437 - 4445
  • [33] RETRACTION: Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis (vol 16, R32, 2012) (Retraction of Vol 16, art no R32, 2012)
    Bitto, Alessandra
    Minutoli, Letteria
    David, Antonio
    Irrera, Natasha
    Rinaldi, Mariagrazia
    Venuti, Francesco S.
    Squadrito, Francesco
    Altavilla, Domenica
    CRITICAL CARE, 2023, 27 (01)
  • [34] A novel HMG CoA reductase inhibitor, NK-104, inhibits MCP-1-induced THP-1 transition from rolling to stable adhesion under physiological flow condition
    Yoshida, M
    Nakamura, Y
    Kawakami, A
    Yasukochi, Y
    CIRCULATION, 2001, 104 (17) : 53 - 53